This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ThousandOaks-based Amgen said Wednesday afternoon that it is cutting 380 jobs from the firm, as part of a corporate restructuring. The firm said it is cutting 226 people in its ThousandOaks headquarters. READ MORE>>.
The Oxnard-ThousandOaks-Ventura metro area has made a list of the top areas where CEOs live , published in this week''s Wall Street Journal. The report--ranking the percentage of residents identified as CEOs--said 1.21% of residents in the metro workforce were CEOs.
HARDATA , a developer of workflow management software for the broadcast and entertainment industry, has set up shop in ThousandOaks, and hired a new President and CEO. The Argentina-based software developer said it has named Philip B. Cox as President and CEO, and opened up its world headquarters in the United States.
ThousandOaks-based Atara Biotherapeutics , which is developing treatments for patients with cancer, autoimmune and infectious disease, has leased a 90,000 square foot building in the Conejo Spectrum, according to developer SARES-REGIS Group.
ThousandOaks-based biotech company Capsida Biotherapeutics says it has opened up a new, 15,000 square-foot facility in ThousandOaks for its gene therapy manufacturing efforts. The company says that building its own manufacturing facility will help it eliminate dependence on ontract manufacturing.
The Ventura County Sheriff''s department reported this morning that it arrested two suspects in ThousandOaks, who were using Uber to help conduct deals. uber drug deal thousandoaks ventura county crime criminal mobile' Apparently, they had been using Uber to drive them to a drug deal. READ MORE>>.
ThousandOaks- and Shanghai-based ThousandOaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round.
ThousandOaks-based biotech giant Amgen said late Monday that it is donating $1M to the Japanese disaster relief efforts. Amgen said the funds will go to Direct Relief International and the International Medical Corps. The funds come both from Amgen and the Amgen Foundation.
ThousandOaks-based Amgen , via its nonprofit foundation, the Amgen Foundation, said Friday that it is giving $1.8M to the Teach For America effort. According to the two, the funding will go towards increasing the number of math and science graduates who are joining Teach For America's teaching corps by 2013.
ThousandOaks-based biotechnology giant Amgen said Tuesday that it plans to cut 2,400 to 2,900 staff, including at its headquarters location, and will also close facilities in both Washington and Colorado. As part of the move, Amgen said it will also consolidate staff into less buildings in the ThousandOaks area.
According to DEMO, ThousandOaks-based Invested.In , Santa Barbara-based Phone Halo , San Diego-based Tastr , and Los Angeles-based Immitter will all be presenting at the technology launch conference. DEMO has traditionally been a major launch event for startups and new technology products.
Move has operations in the ThousandOaks, California area, although it is now based in San Jose. The company was started in ThousandOaks in 1993, and now has 913 employees. Move, Inc. , the operator of the Realtor.com, Move.com, and other related real estate businesses, is being acquired by News Corp. , will pay $21.00
According to the ThousandOaks university, Dorfman's contribution will go towards the construction of the two-story, 27,000-square foot Steven D. Dorfman Center, which will include both classrooms and faculty offices.
ThousandOaks-based Amgen , and Monrovia-based Xencor said Thursday that the two firms are in a co-development dual around a new novel antibody for treating autoimmune diseases. According to the two, Amgen has gained an option to an exclusive, worldwide license on Xencor's XmAb5871.
ThousandOaks-based Eka Technologies said today that it has launched a line of products which provide geo-tagging of photos for Nikon, Canon, Sony, Panasonic, Ricoh, and other digital cameras.
Move, which has major operations in ThousandOaks, said the expanded relationship will expand reach and visibility to AOL's monthly visitors. Move, Inc. , the Campbell-based operator of Realtor.com and Move.com, said Thursday along with AOL that Move has been given the exclusive rights to power AOL's Real Estate homes for sale search.
ThousandOaks-based Teledyne Technologies said last week that it has acquired Photon Machines , a developer of laser-based, laboratory instrumentation. Its corporate headquarters and research labs are in ThousandOaks. Financial terms of the buy were not disclosed. Photon Machines was based in Bozeman, Montana.
ThousandOaks-based biotech giant Amgen said today that its nonprofit arm, the Amgen Foundation , is giving $4.5M in a grant to invest in South Los Angeles schools. Amgen said the grant goes to MLA Partner Schools, an effort which looks to prepare children from South Los Angeles for college and life.
ThousandOaks-based Teledyne Technologies has won a contract from the United States Air Force, for laser eye protection spectacles, initially worth $7.7M, with the potential to be worth as much as $20.4M. The win was made through its Teledyne Scientific and Imaging subsidiary, which has its operations in ThousandOaks and Camarillo.
ThousandOaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals , and now expects its acquisition to complete today. Amgen said the deal is worth $9.7 billion net of estimated cash at Onyx.
ThousandOaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. Details on the funding have not yet been announced by the company. The company apparently is targeting a little over $11.0M in the funding round, which so far includes 12 investors.
Move is based in Campbell, California, with operations in ThousandOaks. SocialBios allows companies and individuals to create interactive "About" pages, which integrate Facebook, LinkedIn, Twitter, Facebook, and other sites. Socialbios is based in Denver. READ MORE>>.
ThousandOaks-based Xirrus , a manufacturer of switching wireless access point hardware, is apparently sponsoring a mixed martial arts event. According to Richard Steele Promotions, Xirrus is sponsoring its "Steele Cage 3" event.
ThousandOaks-based Xirrus , a manufacturer of switching wireless access point hardware, is apparently sponsoring a mixed martial arts event. According to Richard Steele Promotions, Xirrus is sponsoring its "Steele Cage 3" event.
It might be, on news that Kevin Sharer , the former CEO of ThousandOaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. Is Amgen the next source of the healthcare industry's venture capital deals?
According to Newegg, it will launch a pop-up store from August 16-18th in ThousandOaks, California, at The Oaks shopping center. City of Industry-based Newegg , the big online electronics retailer, is making its first foray into the physical, retail market, with a new pop-up store.
ThousandOaks-based Amgen said this morning that it has acquired Turkish pharmaceuticals firm Mustafa Nevzat Pharmaceuticals. Amgen said the deal is worth $700M in cash. Amgen said the acquisition will help to significantly expand its presence in Turkey.
ThousandOaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development.
ThousandOaks-based Amgen and venture firm Kleiner Perkins Caufield & Byers have put their backing behind a new, Westlake Village based drug development firm, Atara Biotherapeutics , in an unusual spinout of technology from the biotech giant.
ThousandOaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease.
ThousandOaks-based Xirrus , the developer of wireless networking equipment, said today that it has named Steven Wastie as its Chief Marketing Officer. Wastie has previously served in similar roles at iPass, Juniper Networks, Inktomi, Netscaape, and At&T Online Services.
ThousandOaks-based Ceres has delayed its IPO, after lowering its IPO pricing estimates this week. According to industry reports , Ceres is delaying the offering until next week. Ceres had initially planned to price its IPO on Thursday. READ MORE>>.
ThousandOaks-based Xirrus , the developer of high performance wireless access points, reported today that it has deployed its products in Gillette Stadium, the home of the New England Patriots. According to Xirrus, its wireless network will serve premium seating areas, as part of the Gillette Stadium Putnam Club.
ThousandOaks-based biotech Amgen is acquiring Iceland-based deCODE Genetics , in a deal worth $415M in cash, the two companies announced this morning. deCODE Genetics is a provider of human genetic research which was founded in 1996.
ThousandOaks-based biotech giant Amgen said this morning that it has agreed to buy KAI Pharmaceuticals , a developer of treatments for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, for $315M in cash. KAI Pharmaceuticals is based in South San Francisco.
Xirrus , the wireless hardware provider based in ThousandOaks, has just raised $10.1M in a funding round, part of an ongoing $11.0M funding, according to a regulatory filing by the company. Details on the funding have not yet been announced by the company.
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.
George Rathmann , the founding CEO of ThousandOaks biotech giant Amgen , has died, the company announced late Monday evening. Rathmann served as founding CEO of Amgen from 1980 to 1988, and was Chairman of the company until 1990.
ThousandOaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. According to Seattle-based Theraclone Sciences , Amgen Ventures was one of the investors in a $10.6M, Series B extension round for the company.
The news for employees over at ThousandOaks-based Amgen got worse on Tuesday, after the company said it is deepening job cuts, and plans to now cut 20 percent of its employees as part of previously announced cutbacks at the company.
ThousandOaks-based Ceres , the developer of seeds for the energy and biofuels industry, said today that its Brazilian subsidiary, Ceres Sementes do Brasil Ltda., is in a deal with Syngenta to develop sweet sorghum-based products to power Brazil's ethanol mills.
ThousandOaks-based biotech giant Amgen said this week that it is planning to build a new manufacturing facility in Singapore, and will invest approximately $200M in the new plant. Amgen also revealed that it will start construction in the next few months.
ThousandOaks-based biotech giant Amgen announced Sunday that it has acquired San Francisco biopharmaceuticals company Onyx Pharmaceuticals , in a deal worth $10.4 Onyx is a developer of biopharmaceuticals used to help patients with cancer. Amgen said it will pay $125 per share inc ash for Onyx Pharmaceuticals. The deal is worth $9.7
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content